flow trial semaglutide kidney outcomes hazard ratio 0.76 nejm 2024 Patients with type 2 #diabetes and chronic disease are at high risk for kidney failure, cardiovascular events, and death. Whether treatment with would mitigate these risks is unknown. ADA 24: FLOW Trial: Kidney
Pay in 4 interest-free payments of $5.21 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5




























